Titrated extract of C. asiatica (TECA) treatment attenuated the development of PA-induced AD by inhibiting the expression of iNOS and COX-2, NF-κB activity, and the release of TNF-α, IL-1β, IL-6, and IgE [40]. This evidence concerns the gene NFKB1 and Alzheimer disease.